Medtronic
Investing in medical technology company Medtronic, creator of 770G hybrid closed-loop system for diabetes patients, is obviously a lucrative move these days. Folks at HealthCor Management know this and bought over 480K shares, increasing its stake by 53 percent in the third quarter of 2020. This accounts for 5.8 percent of the investor’s holdings.
HealthCor’s move made sense, considering 2020 was all about the coronavirus that has claimed millions of lives worldwide. In February 2021, Medtronic reported that its third-quarter revenue topped expectations while its profit fell lower than estimates.
